logo

For the Inventor, By the Inventor

Huntsville, AL, United States of America

Nektar Therapeutics Al, Corporation


USPTO Granted Patents = 45



Forward Citations = 1,196

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Antoni Kozlowski (18 out of 140 patents)

silverMedal Michael David Bentley (14 out of 136 patents)

bronzeMedal Xuan Zhao (13 out of 101 patents)

4.  Xiaoming Shen (11 out of 68 patents)

5.  J Milton Harris (10 out of 89 patents)

6.  Zhihao Fang (6 out of 45 patents)

7.  Michael James Roberts (6 out of 29 patents)

8.  Samuel P McManus (4 out of 94 patents)

9.  Lihong Guo (4 out of 11 patents)

10.  Remy F Gross, Iii (3 out of 13 patents)

11.  Barry R O'Keefe (2 out of 16 patents)

12.  Mary J Bossard (2 out of 40 patents)

13.  M Elizabeth Snell (2 out of 2 patents)

14.  Toshiyuki Mori (2 out of 7 patents)

15.  Michael R Boyd (2 out of 56 patents)


Core Competencies:
Drug Delivery Vehicles
Polymer Conjugates
Hydrolytically Stable Polymers
Multi-arm Block Copolymers
Water-soluble Polymers
Poly(ethylene Glycol) Derivatives
Bioconjugates
Hydrogels
Thioester-terminated Polymers
Sterically Hindered Polymers
Cyanovirin Variants
Active Sulfones

45 patents:

1. 7589157 - Multi-arm block copolymers as drug delivery vehicles (2009-09-15),
2. 7579444 - Polymer-factor IX moiety conjugates (2009-08-25),
3. 7569214 - Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid (2009-08-04),
4. 7547509 - Cyanovirin variant-polymer conjugates (2009-06-16),
5. 7544738 - Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) (2009-06-09),
6. 7528202 - Poly (ethylene glycol) derivatives with proximal reactive groups (2009-05-05),
7. 7511095 - Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith (2009-03-31),
8. 7511094 - Water-soluble polymer alkanals (2009-03-31),
9. 7432331 - Hydrolytically stable maleimide-terminated polymers (2008-10-07),
10. 7432330 - Hydrolytically stable maleimide-terminated polymers (2008-10-07),
11. 7419600 - Method for purifying a branched water-soluble polymer (2008-09-02),
12. 7405266 - Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof (2008-07-29),
13. 7378469 - Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) (2008-05-27),
14. 7329721 - Maleamic acid polymer derivatives and their bioconjugates (2008-02-12),
15. 7316811 - Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles (2008-01-08),
Nektar Therapeutics is a biopharmaceutical company that develops innovative medicines to improve the lives of patients. Their research focuses on oncology, pain management, and immunology, utilizing proprietary drug delivery technology to enhance drug efficacy and safety. Nektar is committed to advancing novel therapeutics through clinical development and collaborations with leading industry partners.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

45 Patents

#10 in Huntsville, AL

#31 in Alabama

#7,497 in US

#14,978 in the World

...
Huntsville, AL, United States of America

Nektar Therapeutics Al, Corporation

Forward Citations = 1,196

25 inventors:

goldMedal Antoni Kozlowski (18 out of 140 patents)

silverMedal Michael David Bentley (14 out of 136 patents)

bronzeMedal Xuan Zhao (13 out of 101 patents)

4.  Xiaoming Shen (11 out of 68 patents)

5.  J Milton Harris (10 out of 89 patents)

Please report any incorrect information to support@idiyas.com
Loading…